Skip to main content Skip to page footer

Endometrial cancer

Logo des NCT Heidelberg Logo des NCT Heidelberg
Suche
×
 

Endometrial cancer

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific TCER® Targeting PRAME, in Patients With Recurrent and/or Refractory Solid Tumors
Phase: I/II
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05958121
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2022-503133-54-00

Title: Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors.
Phase: I
Contact: Kathrin Hettich / Study Nurse
Email-Address: KathrinBarbara.Hettich(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Dirk Jäger
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03686124
EU CTIS/EudraCT: Siehe EU klinisches Studienregister EudraCT: 2019-002370-31

Title: A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients With Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04585750
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: A Phase 1B/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Phase: II
Contact: Beatrice Stranz / Kontaktperson
Email-Address: Beatrice.Stranz(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06330064
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2023-509632-26-00

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

Title: Beurteilung gynäkologischer Beckentumoren mittels MRT
Phase: N/A
Contact: Studienzimmer E010, Radiologie, dkfz / Kontaktperson
Email-Address: studien-radiologie(at)dkfz-heidelberg.de
Clinical Investigator: Dr. med. Theresa Mokry
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: